GoodRx Holdings, Inc. (GDRX) Reports In-Line Q1 EPS ; Offers Guidance

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q1 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $194.01 million versus the consensus estimate of $185.28 million.

2026 Outlook:-

Revenue between $765 - $785 million vs consensus $764.8 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Daiwa Securities Downgrades Pinduoduo Inc. (PDD) to Hold
• Morgan Stanley upgrades CDW on stronger AI-driven server demand